Lonza Says in Talks to Buy Capsugel; Deal Could Top $5 Bln – Sources


Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems.
Reuters Health Information